AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,394,852 | -2.7% | 248,889 | +0.0% | 0.23% | 0.0% |
Q2 2023 | $17,876,756 | +74.1% | 248,772 | +49.4% | 0.23% | +56.9% |
Q1 2023 | $10,270,028 | -42.9% | 166,505 | -28.6% | 0.14% | -46.3% |
Q4 2022 | $17,978,617 | -9.4% | 233,095 | -3.4% | 0.27% | -44.5% |
Q2 2020 | $19,853,000 | +28.5% | 241,284 | -8.1% | 0.48% | -6.4% |
Q1 2020 | $15,445,000 | -45.8% | 262,541 | -4.8% | 0.52% | -31.9% |
Q4 2019 | $28,498,000 | – | 275,717 | – | 0.76% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |